-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Olema Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
- Olema Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.63M, a 37.1% increase year-over-year.
- Olema Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $20.6M, a 16% increase year-over-year.
- Olema Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.3M, a 8.35% decline from 2022.
- Olema Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18.8M, a 18.3% increase from 2021.
- Olema Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15.9M, a 417% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)